Screening for Malignancy After Augmentation Cystoplasty in Children With Spina Bifida: A Decision Analysis

Abstract

Annual screening for malignancy among patients with spina bifida with cystoplasty using cystoscopy and cytology is unlikely to be cost effective at commonly accepted willingness to pay thresholds. This conclusion is sensitive to a higher than expected risk of malignancy and to highly optimistic estimates of screening effectiveness.